The Democratic Progressive Party (DPP) yesterday said the Chinese Nationalist Party (KMT) had launched another smear campaign against DPP presidential candidate Tsai Ing-wen (蔡英文) over her involvement in Yu Chang Biologics Co (宇昌生技股份有限公司), saying the KMT’s allegation lacked solid evidence.
The KMT said Tsai received improper benefits from the firm when she served in government, but according to DPP spokesperson Chen Chi-mai (陳其邁), the KMT has purposely chosen to release only partial information and made the allegation purely on speculation.
A pair of declassified documents with Tsai’s signature dating from the time she served as vice premier were provided to the legislature yesterday by Council for Economic Planning and Development (CEPD) Minister Christina Liu (劉憶如) in the presence of several KMT lawmakers and political pundit Clara Chou (周玉蔻).
Photo: Chang Chia-ming, Taipei Times
Academia Sinica President Wong Chi-huey (翁啟惠), one of the scientists who invited Tsai to join Yu Chang, told reporters on Sunday that the controversy has been “unfair” to Tsai.
In a press release yesterday, Wong said Tsai should be commended for her assistance in developing the biotech industry.
Chen Mei-ling (陳美伶), former deputy secretary-general of the Executive Yuan, also told reporters yesterday that Tsai did not violate “revolving door” regulations on public officials because the regulation does not apply to deputies and the biotech industry was not under the scope of Tsai’s supervision at the time.
Chen said the so-called scandal is the result of collaboration between the KMT, its legislators, government officials, some media outlets and political pundits, and comes about a month before the presidential election, which stands to benefit President Ma Ying-jeou’s (馬英九) re-election campaign.
Chen said Liu had failed to maintain her administrative neutrality when she said Tsai had been called a shoo-in as Yu Chang chairperson at an investors’ conference on March 31, 2007, when she was still vice premier.
The KMT said Tsai was guilty of a conflict of interest because of her involvement with Yu Chang after she left office in August 2007 and she later became chairperson of the firm, which received investment from the state-owned National Development Fund (NDF), adding that Tsai had received NT$100 million (then US$3.3 million) when she sold her shares in the company in 2009.
The KMT has questioned Tsai’s role in the case on at least four grounds — investment of Tsai’s family businesses, her position as Yu Chang’s chairperson after leaving office, the classification of related documents as top-secret and suspected profiteering by Tsai and her family.
Tsai was keen on promoting the biotech industry as one of the nation’s strategic sectors when she served as vice premier and did not decide to persuade her family to invest after the start-up failed to attract investors in its initial stage, former CEPD chairperson Ho Mei-yueh (何美玥) said during a press conference.
“The accusation of Tsai wanting to profit from this project is far from the truth. Without the Tsai family’s funding, the company would not have been created in time for the deal,” she said.
Ho added that it was not possible that Tsai paved her way to the position of Yu Chang’s chairperson because she would not have resigned as vice premier if former premier Su Tseng-chang (蘇貞昌) did not step down after losing the DPP primary for the 2008 presidential election.
She decided to keep the document on the establishment of Yu Chang and a bid for Genentech confidential because there were foreign competitors vying for the deal at the time, Ho said.
“The documents were classified as ‘official secret’ — not ‘national secret’ — and could be declassified after the contract was signed,” she said.
Tsai’s resignation as vice premier in May 2007 and her assuming the DPP’s leadership position in May 2008 could have never been planned and that should be enough to eliminate all the conspiracy theories, said Lien Yuan-lung (連元龍), a lawyer representing the DPP, adding that the project was “tailor-made” for Tsai.
Tsai did not say her family would invest in Yu Chang in the official documents nor did her family members attend the investors’ conference, Lien said, adding that Tsai said publicly on Sept. 15, 2007, that her family would withdraw its investment once the project was fully funded.
The NDF’s funding of the company did not bypass the required screening procedures because the NDF approved the funding on April 17, 2007, he said.
The only difference between the funding and other projects, he said, was that it was planned as a “special project” by a top-down decision, the same process as when the Ma administration approved the investment of NT$5 billion in China Airlines in 2009, which posted a NT$3.8 billion loss that year.
In response to accusations by the KMT that Tsai masterminded the passage of the Biotech and New Pharmaceuticals Industry Development Act (生技新藥產業發展條例) in 2007 to help establish Yu Chang, the DPP said that piece of legislation was pushed through by Legislative Speaker Wang Jin-pyng (王金平), who himself has said the act was beneficial to the nation.
According to the legislature’s gazette, Wang played an active role in the enactment and passage of the act and was part of efforts jointly exerted by the legislature, then dominated by the KMT, and executive branches to offer various incentives to boost the sector.
The act was supported by 104 lawmakers, out of a total of 225 seats, across party lines, led by Wang and then-legislative deputy speaker David Chung (鍾榮吉) of the People First Party, marking the first and only time in the nation’s history that a bill was sponsored by the legislative speaker and the deputy speaker.
Sent to the legislature’s clerk on June 6, 2007, the act swiftly cleared the legislature before the legislative session went into summer recess on June 15, which would not have been possible without consensus among political parties, as the political climate at that time was confrontational.
“The act has benefited the nation. If it hadn’t been passed at that time, it was likely that the biotech and new pharmaceutical industry was doomed,” Wang said today.
Wang said government officials involved in the development of the industry and professionals could corroborate his argument.
“Go ahead and ask them their views on the act,” Wang said.
A signaling system malfunction disrupted high-speed rail (HSR) services beginning at 8am today, with trains temporarily reduced to three northbound and three southbound trains per hour as authorities conduct inspections. The malfunction occurred on a section of track in Miaoli County during pre-operation checks early this morning, forcing northbound and southbound trains to use a single track, the HSR operator said. The regular schedule has been replaced with three hourly trains offering only nonreserved seating in each direction, stopping at every station, it said, adding that business class cars would still have reserved seating. Departures from terminal stations are scheduled at the top
Taiwan is still in the process of assessing the possibility of recruiting workers from Eswatini, the Ministry of Foreign Affairs said yesterday, adding that its goal is to help Eswatini upgrade its vocational training centers. If there are plans to recruit workers from Eswatini, safeguarding national security, protecting public health and ensuring the employment rights of Taiwanese would be prerequisites, Department of West Asian and African Affairs Director-General Yen Chia-liang (顏嘉良) told a news conference. Key considerations would also include filling labor shortages in specific industries, and fostering bilateral professional and technical exchanges, he said. Yen was asked about the progress of labor
A US uncrewed surface vessel (USV) encountered multiple Chinese warships during an autonomous transit of the Taiwan Strait, US defense company Seasats said in a statement on Wednesday. Seasats announced that a Lightfish USV had completed the first autonomous transit of the Taiwan Strait. Over five days, the USV traversed the entire length of the Strait while constantly monitoring surface vessel traffic, the company said. The Lightfish encountered multiple Chinese warships, one of which was a Chinese People’s Liberation Army Navy (PLAN) Type 056 corvette, it said. The Chinese vessels were operating “well within Taiwan’s exclusive economic zone without transmitting their identity via the
VERBOSE VESSELS: A CGA cutter and a China Coast Guard exchanged verbal barbs for more than a day in Taiwanese-controlled waters before the Chinese vessel left The Taiwanese and Chinese coast guards had a standoff near the strategically located Pratas Islands (Dongsha Islands, 東沙群島) in the north of the South China Sea, the Coast Guard Administration (CGA) said yesterday. The two sides engaged in intense radio exchanges over sovereignty claims during the 33-hour standoff. China Coast Guard vessel 3501 eventually left the restricted waters, 26.6 nautical miles (49.2km) west of the Pratas Islands, at 5pm yesterday, the CGA said. Lying approximately between southern Taiwan and Hong Kong, the Taiwan-controlled Pratas are seen by some security experts as vulnerable to Chinese attack due to their distance — more than
RSS